These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 709539)

  • 41. The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
    Levi JA; Wiernik PH
    Cancer; 1977 May; 39(5):2158-65. PubMed ID: 404027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum copper assay as a biochemical marker to assess the response to therapy in Hodgkin's disease.
    Kesava Rao KV; Shetty PA; Bapat CV; Jussawalla DJ
    Indian J Cancer; 1977 Dec; 14(4):320-4. PubMed ID: 612553
    [No Abstract]   [Full Text] [Related]  

  • 43. Interpreting serum copper levels in Hodgkin's disease.
    Hrgovcic MJ; Tessmer CF; Mumford DM; Ong PS; Gamble JF; Shullenberger CC
    Tex Med; 1975 Feb; 71(2):53-63. PubMed ID: 1111152
    [No Abstract]   [Full Text] [Related]  

  • 44. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D; Greenberg M; Fitzgerald A
    Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators.
    Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
    Haematologica; 1979 Aug; 64(4):416-32. PubMed ID: 121577
    [No Abstract]   [Full Text] [Related]  

  • 46. Prolonged observations on variations in the serum copper in Hodgkin's disease.
    Warren RL; Jelliffe AM; Watson JV; Hobbs CB
    Clin Radiol; 1969 Jul; 20(3):247-56. PubMed ID: 5808043
    [No Abstract]   [Full Text] [Related]  

  • 47. Value of serum copper measurement in acute leukaemia of childhood.
    El-Haddad S; Mahfouz M; Magahed Y; Mahmoud F; Kamel M; Ali MA
    Gaz Egypt Paediatr Assoc; 1977 Jan; 26(1):67-72. PubMed ID: 274437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report.
    Jenkin D; Freedman M; McClure P; Peters V; Saunders F; Sonley M
    Cancer; 1979 Jul; 44(1):80-6. PubMed ID: 455267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum copper and zinc levels and copper/zinc ratio in pediatric non-Hodgkin's lymphoma.
    Gözdaşoğlu S; Cavdar AO; Arcasoy A; Akar N
    Acta Haematol; 1982; 67(1):67-70. PubMed ID: 6800204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of the blood copper in Hodgkin's disease.
    PAGLIARDI E; GIANGRANDI E
    Acta Haematol; 1960 Oct; 24():201-12. PubMed ID: 13732060
    [No Abstract]   [Full Text] [Related]  

  • 51. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias.
    Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J
    Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.
    Bodis S; Henry-Amar M; Bosq J; Burgers JM; Mellink WA; Dietrich PY; Dupouy N; Noordijk EM; Raemaekers JM; Thomas J
    J Clin Oncol; 1993 Feb; 11(2):225-32. PubMed ID: 8426198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serum copper levels in Hodgkin's disease].
    Cohen Y; Epelboim R; Haim N; Zinder O
    Harefuah; 1984 Mar; 106(6):252-4. PubMed ID: 6745761
    [No Abstract]   [Full Text] [Related]  

  • 54. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 55. The erythrocyte sedimentation rate. Guidelines for rational use.
    Sox HC; Liang MH
    Ann Intern Med; 1986 Apr; 104(4):515-23. PubMed ID: 3954279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 57. The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
    Molin D; Glimelius B; Sundström C; Venge P; Enblad G
    Leuk Lymphoma; 2001 Jul; 42(3):457-65. PubMed ID: 11699410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is higher income and educational status associated with poorer outcome in patients with Hodgkin's disease?
    Holzner B; Fischhofer M; Kemmler G; Kopp M; Sperner-Unterweger B; Krugmann J; Dirnhofer S; Greil R
    Eur J Haematol; 2004 Nov; 73(5):318-24. PubMed ID: 15458510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Zinc and copper blood levels in patients with Hodgkin's disease].
    Adamczyk B; Glińska H; Kulpa J; Pawlicki M
    Nowotwory; 1974; 24(1):9-15. PubMed ID: 4824380
    [No Abstract]   [Full Text] [Related]  

  • 60. Relationship between serum copper and bone marrow blasts in acute leukaemia.
    Legutko L
    Haematologia (Budap); 1977; 11(3-4):297-300. PubMed ID: 283968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.